FDA approves Merck’s cholesterol-lowering medication
FDA Approves New Cholesterol-Lowering Drug by Merck On Thursday, the U.S. Food and Drug Administration (FDA) announced its approval of a new cholesterol-lowering medication from Merck & Co. This marks the first oral drug in a category typically filled with injectable options, potentially expanding treatment accessibility for those at risk for heart disease. Branded Lipfendra, […]